{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-055834","form_type":"8-K","ticker":"HOTH","cik":"0001711786","company_name":"Hoth Therapeutics, Inc.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.433872+00:00","generated_at":"2026-05-19T01:34:47.536142+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Hoth Therapeutics regains Nasdaq minimum bid price compliance after 10-day closing above $1.00","bullets":["Received Nasdaq notice on June 18, 2025 confirming compliance with Listing Rule 5550(a)(2) after 10 consecutive business days at or above $1.00.","Compliance period ran from June 4 through June 17, 2025; Nasdaq matter is now closed.","CEO Robb Knie stated the milestone reflects growing market confidence and positions for value creation in 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-055834","json":"https://secwatch.observer/filing/0001213900-25-055834.json","markdown":"https://secwatch.observer/filing/0001213900-25-055834.md","text":"https://secwatch.observer/filing/0001213900-25-055834.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711786/000121390025055834/0001213900-25-055834-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711786/000121390025055834/ea0246204-8k_hoth.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T01:34:47.536142+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}